Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine for Skin Graft Donor Site Pain
NCT01999153Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Dec 2013
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in pain, sponsored by Rouen University Hospital. Primary endpoint: Class II analgesic consumption at 5 days. Started Dec 2013; status: completed.
02
Drugs
ropivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT01999153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01999153.